Estimated Median Waiting Time for Organ Procurement and Transplantation Network Human Immunodeficiency Virus Organ Policy Equity Act Variance Kidney Candidates: A Propensity Score Matched Analysis.

IF 2.6 4区 医学 Q3 IMMUNOLOGY
Amber R Fritz, Jesse Howell, Cameron R Wolfe, Samantha M Noreen, David K Klassen
{"title":"Estimated Median Waiting Time for Organ Procurement and Transplantation Network Human Immunodeficiency Virus Organ Policy Equity Act Variance Kidney Candidates: A Propensity Score Matched Analysis.","authors":"Amber R Fritz, Jesse Howell, Cameron R Wolfe, Samantha M Noreen, David K Klassen","doi":"10.1111/tid.14411","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Prior to the 2013 HIV Organ Policy Equity (HOPE) Act, which enabled research on the transplantation of solid organs from donors with human immunodeficiency virus (HIV) to candidates living with HIV, it was prohibited for HIV+ individuals to donate organs in the United States. In 2015, alongside the release of HOPE Act research criteria, the Organ Procurement and Transplantation Network (OPTN) made organ allocation policy and system changes to allow HIV+ to HIV+ transplantation.</p><p><strong>Methods: </strong>The OPTN database was queried for all adult kidney registrations ever waiting from November 23, 2015, to December 31, 2022; the cohort was split into a HOPE cohort (ever willing to accept an HIV+ kidney) and a non-HOPE cohort (all remaining). Estimated median waiting times (eMWTs) were calculated using a period prevalent Kaplan-Meier approach; HOPE registrations were matched 1:5 without replacement to non-HOPE registrations using a logistic regression propensity score.</p><p><strong>Results: </strong>Using all waiting time, the eMWT for the HOPE cohort was significantly lower than the matched non-HOPE cohort (3.04 years [95% confidence interval {CI}: 2.70, 3.41] versus 5.88 years [95% CI: 5.65, 6.18]). This trend persisted when estimating MWT using other active time and geographical definitions (ignoring geography and donor service area).</p><p><strong>Conclusion: </strong>These results suggest that transplantation through the OPTN HOPE variance yields decreases eMWT, perhaps reducing the medium and longer-term impacts of living with HIV.</p>","PeriodicalId":23318,"journal":{"name":"Transplant Infectious Disease","volume":" ","pages":"e14411"},"PeriodicalIF":2.6000,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplant Infectious Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/tid.14411","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Prior to the 2013 HIV Organ Policy Equity (HOPE) Act, which enabled research on the transplantation of solid organs from donors with human immunodeficiency virus (HIV) to candidates living with HIV, it was prohibited for HIV+ individuals to donate organs in the United States. In 2015, alongside the release of HOPE Act research criteria, the Organ Procurement and Transplantation Network (OPTN) made organ allocation policy and system changes to allow HIV+ to HIV+ transplantation.

Methods: The OPTN database was queried for all adult kidney registrations ever waiting from November 23, 2015, to December 31, 2022; the cohort was split into a HOPE cohort (ever willing to accept an HIV+ kidney) and a non-HOPE cohort (all remaining). Estimated median waiting times (eMWTs) were calculated using a period prevalent Kaplan-Meier approach; HOPE registrations were matched 1:5 without replacement to non-HOPE registrations using a logistic regression propensity score.

Results: Using all waiting time, the eMWT for the HOPE cohort was significantly lower than the matched non-HOPE cohort (3.04 years [95% confidence interval {CI}: 2.70, 3.41] versus 5.88 years [95% CI: 5.65, 6.18]). This trend persisted when estimating MWT using other active time and geographical definitions (ignoring geography and donor service area).

Conclusion: These results suggest that transplantation through the OPTN HOPE variance yields decreases eMWT, perhaps reducing the medium and longer-term impacts of living with HIV.

器官获取与移植网络人体免疫缺陷病毒器官政策公平法案差异肾脏候选者的估计中位等待时间:倾向得分匹配分析
背景:2013 年《HIV 器官政策公平(HOPE)法案》(HIV Organ Policy Equity,简称 HOPE 法案)允许研究将人体免疫缺陷病毒(HIV)捐献者的实体器官移植给 HIV 感染者候选人,在此之前,美国禁止 HIV+ 感染者捐献器官。2015 年,在发布 HOPE 法案研究标准的同时,器官获取与移植网络(OPTN)对器官分配政策和系统进行了修改,允许 HIV+ 对 HIV+ 进行器官移植:方法:我们查询了 OPTN 数据库中从 2015 年 11 月 23 日至 2022 年 12 月 31 日所有曾经等待过的成人肾脏登记情况;该队列被分为 HOPE 队列(曾经愿意接受 HIV+ 肾脏)和非 HOPE 队列(所有剩余者)。估计的中位等待时间(eMWTs)是采用周期流行的 Kaplan-Meier 方法计算得出的;采用逻辑回归倾向评分法将 HOPE 注册者与非 HOPE 注册者进行 1:5 的匹配,不进行替换:使用所有等待时间,HOPE 队列的 eMWT 显著低于匹配的非 HOPE 队列(3.04 年 [95% 置信区间 {CI}:2.70,3.41] 对 5.88 年 [95% CI:5.65,6.18])。在使用其他活动时间和地域定义(忽略地域和捐献者服务区域)估算MWT时,这一趋势依然存在:这些结果表明,通过 OPTN HOPE 差异产生的移植可降低 eMWT,从而减轻艾滋病病毒感染者的中长期影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Transplant Infectious Disease
Transplant Infectious Disease 医学-传染病学
CiteScore
5.30
自引率
7.70%
发文量
210
审稿时长
4-8 weeks
期刊介绍: Transplant Infectious Disease has been established as a forum for presenting the most current information on the prevention and treatment of infection complicating organ and bone marrow transplantation. The point of view of the journal is that infection and allograft rejection (or graft-versus-host disease) are closely intertwined, and that advances in one area will have immediate consequences on the other. The interaction of the transplant recipient with potential microbial invaders, the impact of immunosuppressive strategies on this interaction, and the effects of cytokines, growth factors, and chemokines liberated during the course of infections, rejection, or graft-versus-host disease are central to the interests and mission of this journal. Transplant Infectious Disease is aimed at disseminating the latest information relevant to the infectious disease complications of transplantation to clinicians and scientists involved in bone marrow, kidney, liver, heart, lung, intestinal, and pancreatic transplantation. The infectious disease consequences and concerns regarding innovative transplant strategies, from novel immunosuppressive agents to xenotransplantation, are very much a concern of this journal. In addition, this journal feels a particular responsibility to inform primary care practitioners in the community, who increasingly are sharing the responsibility for the care of these patients, of the special considerations regarding the prevention and treatment of infection in transplant recipients. As exemplified by the international editorial board, articles are sought throughout the world that address both general issues and those of a more restricted geographic import.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信